RNLXY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RNLXY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Unearned Income only applies to banks.
Howard Jr Doran | officer: Chief Business Officer | C/O HOLOGIC, INC., 35 CROSBY DRIVE, BEDFORD MA 01730 |
Daniel J Levangie | director | 85 SWANSON ROAD, BOXBOROUGH MA 01719 |
Thomas H Mclain | officer: President | NABI PHARMACEUTICALS, 5800 PARK OF COMMERCE BLVD N.W., BOCA RATON FL 33487 |
Timothy J Scannell | director | 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002 |
Catherine Coste | director | 966 OCHO RIOS DR, DANVILLE CA 94526 |
Mount Sinai Health System, Inc. | 10 percent owner | 150 EAST 42ND STREET, SUITE 2-B.17, NEW YORK NY 10017 |
Icahn School Of Medicine At Mount Sinai | 10 percent owner | 1 GUSTAVE L. LEVY PLACE, NEW YORK NY 10029 |
Christopher Mills | director, 10 percent owner | C/O RENALYTICS PLC, FINSGATE, 5-7 CRANWOOD STREET, LONDON X0 EC1V 9EE |
O. James Sterling | officer: Chief Financial Officer | C/O STAR MOUNTAIN CREDIT OPPS FUND, LP, 140 E. 45TH STREET, 37TH FLOOR, NEW YORK NY 10017 |
Mount Sinai Hospitals Group, Inc. | 10 percent owner | ONE GUSTAVE L. LEVY PLACE, NEW YORK NY 10029 |
Sinai Hospital Mount | 10 percent owner | ONE GUSTAVE L LEVY PLACE, NEW YORK NY 10029 |
Fergus Fleming | director, officer: Chief Technical Officer | C/O RENALYTIX PLC, FINSGATE, 5-7 CRANWOOD STREET, LONDON X0 EC1V 9EE |
Chirag R. Parikh | director | C/O RENALYTIX PLC, FINSGATE, 5-7 CRANWOOD STREET, LONDON X0 EC1V 9EE |
Erik Lium | director | C/O RENALYTIX PLC, FINSGATE, 5-7 CRANWOOD STREET, LONDON X0 EC1V 9EE |
James Renwick Mccullough | director, officer: Chief Executive Officer | C/O RENALYTIX PLC, FINSGATE, 5-7 CRANWOOD STREET, LONDON X0 EC1V 9EE |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.